News & Events
We thank the EU and are proud to share the following algae video for the IBD project at the MIGAL Institute. The project received an impressive grant of 7.5 million euros to further fund the research of Dr. Dorit Avni, lead researcher at the MIGAL Institute, in the field of algae and coordinator of Algae4IBD.
Algae4IBD focused on the treatment of inflammatory bowel disease (IBD), including Crohn's and colitis, and their prevention.
We are proud to show you a new video we have produced.
The Migal Research Institute engages in advanced practical research as part of the Galilee ecosystem and the local community.
We researched, discovered, filmed, edited (well, not alone) and produced a video that gives a glimpse into our research activities.
We are excited to share with you our progress and collaborative relationships.
Migal Institute for Scientific Research in the Galilee invites you and you to an evening that is all about science On Thursday 3/12 between the hours of 16: 00-23: 00.
This year you will sit at home, tour our virtual space and choose from a variety of activities we have prepared for you: scientific experiments for the whole family, quizzes, an exhibition tour, lectures, demonstrations, a round table discussion with researchers and more. To enter, click on the link http://madalay.la/migal
The ENABLING Final Conference was held at EIMA Digital Preview on November 13, 2020. The EIMA Digital Preview -was the virtual fair organised by Federunacoma as a pre-event to the EIMA International Fair 2020, which was to be held in November. EIMA will now be held in February 2021, due to COVID-19 related impediments.
The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics
Initiated by the UAE - First online professional symposium with the participation of an Israeli, CEO of the MIGAL Institute, and other global experts to develop a COVID-19 vaccine
By Dana Elimelech
The MIGAL Galilee Research Institute, which is developing a vaccine for the novel coronavirus via its subsidiary MigVax, uses the Oracle Cloud Infrastructure to support its research efforts as part of the global mobilization to combat COVID-19. As part of the development process, the researchers have been analyzing huge databases of viral genetic sequences in order to identify the virus’s weaknesses.